The Korean Journal of Pain

  • 제20권2호
  • /
  • Pages.190-194
  • /
  • 2007
  • /
  • 2005-9159(pISSN)
  • /
  • 2093-0569(eISSN)
대한통증학회 (The Korean Pain Society)
권호 표지
DOI QR코드

DOI QR Code

케타민 피하 주입을 이용한 복합부위통증증후군 환자의 통증 관리 - 증례보고 -

Pain Management via a Subcutaneous Infusion of Ketamine in a Patient with Complex Regional Pain Syndrome - A case report -

  • 서정훈 (서울대학교 의과대학 마취통증의학교실) ;
  • 구미숙 (서울대학교 의과대학 마취통증의학교실) ;
  • 남상건 (서울대학교 의과대학 마취통증의학교실) ;
  • 신화용 (서울대학교 의과대학 마취통증의학교실) ;
  • 최용민 (서울대학교 의과대학 마취통증의학교실) ;
  • 조지연 (서울대학교 의과대학 마취통증의학교실) ;
  • 이상철 (서울대학교 의과대학 마취통증의학교실) ;
  • 김용철 (서울대학교 의과대학 마취통증의학교실)
  • Suh, Jeong Hun (Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine) ;
  • Koo, Mi Suk (Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine) ;
  • Nahm, Francis Sahngun (Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine) ;
  • Shin, Hwa Yong (Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine) ;
  • Choi, Yong Min (Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine) ;
  • Jo, Ji Yon (Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine) ;
  • Lee, Sang Chul (Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine) ;
  • Kim, Yong Chul (Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine)
  • 투고 : 2007.09.19
  • 심사 : 2007.11.13
  • 발행 : 2007.12.10
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Complex regional pain syndrome (CRPS), which is a syndrome that is defined by pain and sudomotor and/or vasomotor instability, is usually resistant to conventional treatment. Here, a case involving a 30-year-old male patient with CRPS type I who showed severe intractable right shoulder pain with allodynia and hyperalgesia despite being treated with oral medications, nerve blocks including thoracic sympathetic neurolysis, and spinal cord stimulation is described. The patient frequently visited the emergency room due to severe uncontrollable breakthrough pain. Although a favorable effect was observed in response to intermittent ketamine infusion therapies that were performed on an outpatient basis, acute exacerbation of pain occurred frequently during the night and could not be controlled. Therefore, subcutaneous ketamine infusion therapy using a patient-controlled analgesic system was attempted and found to effectively control acute exacerbation of pain during 6 weeks of infusion without serious complications.

키워드

참고문헌

  1. Mannion RJ. Woolf CJ: Pain mechanisms and management: a central perspective. Clin J Pain 2000; 16(Suppl 3): 144-56 https://doi.org/10.1097/00002508-200006000-00008
  2. Fisher K, Ccxlcrrc TJ, Hagen NA: Targeling Ihe N-melhyl-D- aspartate receptor for chronic pain management: Preclinical animal siudies, recent clinical experience and future research directions. J Pain Symptom Manage 2000: 20: 358-73 https://doi.org/10.1016/S0885-3924(00)00213-X
  3. Woolf CJ. Mannion RJ: Neuropathic pain: aetiology. symptoms, mechanisms, and management. Lancet 1999; 353: 1959-64 https://doi.org/10.1016/S0140-6736(99)01307-0
  4. Woolf CJ: American College of Physic ians. American Physiological Society: Pain : moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 2004; 140: 441-51 https://doi.org/10.1001/archinte.140.3.441
  5. South SM, Kohno T, Kaspar BK, Hegarty D, Vissd B, Drake CT, et al: A conditional deletion of the NRI subunit of the NMDA receptor in adult spinal cord dorsal horn reduces NMDA currents and injury-induced pain. J Neurosci 2003; 23: 5031-40 https://doi.org/10.1523/JNEUROSCI.23-12-05031.2003
  6. Srubhaug A, Breivik H, Eide PK, Kreuncn M, Foss A: Mapping of punctuate hyperal gesia around a surgical incision demonstrates thai kctaminc is a powerful suppressor of central sensitization 10 pain following surgery. Acta Anacsthesiol Scand 1997; 41: 1124-32 https://doi.org/10.1111/j.1399-6576.1997.tb04854.x
  7. Villanueva-Perez VL. Cerda-Olmedo G. Samper JM. Minguez A. Monsalve V, Bayona MJ. et al: Oral keraminc for the treatment of type I complex regional pain syndrome. Pain Pract 2007; 7: 39-43 https://doi.org/10.1111/j.1533-2500.2007.00109.x
  8. Orser SA, Pcnncfathcr PS, MacDonald JF: Multiple mechanisms of kctaminc blockade of Ncmcthyl-Dcaspartatc receptors. Anesthesiology 1997; 86: 903 -17 https://doi.org/10.1097/00000542-199704000-00021
  9. Smith DJ, Boucbal RL. deSancris CA, Monroe PJ, Amedro JB. Perrotti JM. et al: Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro. Neuropharmacology 1987; 26: 1253-60 https://doi.org/10.1016/0028-3908(87)90084-0
  10. Eide PK, Stubhaug A, Brcivik H, Oye I: Reply to S.T. Meller: Ketamine: relief from chronic pain through actions at the NMOA receptor. Pain 1997; 72: 289-91 https://doi.org/10.1016/S0304-3959(96)03263-0
  11. Haley JE, Sullivan AF, Dickenson AH: Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociccptio n in the rat. Brain Res 1990; 518: 218-26 https://doi.org/10.1016/0006-8993(90)90975-H
  12. Cbaplan SR. Malmberg AB. Yaksh TL: Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia ami nerve injury evoked allodynia in the rat. J Pharmacol Exp Ther 1997; 280: 829-38
  13. Eidc K. Stubhaug A. Oye I. Brcivik H: Cominuolls subcutaneous adminislrat ion of Ihc N-methyl-D-aspank acid (NMDA) receplor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain 1995 : 61: 221-8 https://doi.org/10.1016/0304-3959(94)00182-E
  14. Kryslal JH, Karpcr LP, Scihyl JP, Freeman GK, Delancy R, Bremner JD, et al: Subanesthetie effect of the noncompetitivc NMDA antagonist, ketamine, in humans : Psychotomimetic, pcrcepilial, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994: 51: 199-21 https://doi.org/10.1001/archpsyc.1994.03950030035004
  15. Hocking G, Cous ins MJ: Ketamine in chronic pain management : an evidence-based review. Anesth Analg 2003: 97: 1730-9 https://doi.org/10.1213/01.ANE.0000086618.28845.9B
  16. Kiefer RT, Rohr P, Ploppa A, Altemcyer KH, Schwarzman RJ: Complete recovery from intractable complex regional pain syndrome, CRPS-type I, following anesthetic ketamine and midazolam. Pain Pract 2007; 7: 147-50 https://doi.org/10.1111/j.1533-2500.2007.00123.x
  17. Koffler SP, Hampstead BM, Irani F, Tinker J, Kiefer RT, Rohr P, et al: The neurocognitive effects of 5 day anesthetic ketamine for the treatment of refractory complex regional pain syndrome. Arch Clin Neuropsychol 2007; 22: 719-29 https://doi.org/10.1016/j.acn.2007.05.005
  18. Correll GE, Maleki J, Gracely EJ, Muir JJ, Harbut RE: Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med 2004; 5: 263-75 https://doi.org/10.1111/j.1526-4637.2004.04043.x
  19. Goldberg ME, Domsky R, Scaringe D, Hirsh R, Dotson J, Sharaf I, et al: Multi-clay low dose ketamine infusion for the treatment of complex regional pain syndrome. Pain Physician 2005; 8: 175-9
  20. Mercadante S, Lodi F, Sapio M, Calligara M, Serretta R: Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain. J Pain Symptom Manage 1995; 10: 564-8 https://doi.org/10.1016/0885-3924(95)00102-5
  21. Webster LR, Walker MJ: Safety and efficacy of prolonged outpatient ketamine infusions for neuropathic pain. Am J Ther 2006; 13: 300-5 https://doi.org/10.1097/00045391-200607000-00004

피인용 문헌

  1. Preemptive Use of Ketamine on Post Operative Pain of Appendectomy vol.24, pp.3, 2011, https://doi.org/10.3344/kjp.2011.24.3.137